334 Participants Needed

Surgery vs Casting for Children's Elbow Fractures

(COMET Trial)

CS
JB
CY
Overseen ByCandace Young, BS
Age: < 18
Sex: Any
Trial Phase: Academic
Sponsor: Ann & Robert H Lurie Children's Hospital of Chicago
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 1 JurisdictionThis treatment is already approved in other countries

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial compares two treatments for children with a specific type of elbow fracture called a medial epicondyle fracture. Researchers aim to determine if surgery, known as open reduction and internal fixation (ORIF), results in better movement and healing than using a cast without surgery. Suitable participants have experienced this type of elbow fracture within the last 10 days and can manage oral medication while keeping their arm still in a cast. As an unphased trial, this study provides a unique opportunity to contribute to medical knowledge and potentially enhance future treatment options for children with similar fractures.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It is best to discuss this with the trial coordinators or your doctor.

What prior data suggests that this protocol is safe for children's elbow fractures?

Research shows that open reduction and internal fixation (ORIF) is generally safe for treating elbow fractures in children. ORIF involves surgery where screws or wires hold the bone in place. Studies have found that this method leads to good recovery and is well-tolerated by children. For instance, one study found that using screws that dissolve over time in ORIF is both feasible and safe, resulting in positive recovery outcomes.

However, some complications can occur, such as avascular necrosis, where the bone loses its blood supply. Fortunately, such complications are rare, and most children recover well.

Overall, ORIF has been used for a long time, and evidence well-supports its safety in similar cases. Discussing any concerns with a healthcare provider can provide more personalized insights.12345

Why are researchers excited about this trial?

Researchers are excited about the treatment options for children's elbow fractures because they offer different approaches to healing. The open reduction and internal fixation (ORIF) technique is unique because it involves surgically realigning the fractured bones and securing them with hardware, which can potentially lead to quicker and more precise healing. On the other hand, the non-operative immobilization method uses a cast to stabilize the fracture without surgery, aiming for a less invasive recovery. These contrasting methods allow researchers to explore which approach might offer better outcomes in terms of healing time, pain management, and overall recovery for young patients.

What evidence suggests that this trial's treatments could be effective for children's elbow fractures?

Research has shown that open reduction and internal fixation (ORIF) effectively treats elbow fractures in children. ORIF involves surgery to reposition and stabilize the bone, promoting proper healing and maintaining elbow stability. For example, one study found that using ORIF with special screws that dissolve over time was a safe and successful treatment for fractures. Another study noted that this surgical method might improve the chances of correct bone healing. Overall, ORIF has been linked to good results and few complications. In this trial, some participants will receive ORIF, while others will be treated with non-operative immobilization using a cast, another treatment option under study.13678

Who Is on the Research Team?

JJ

Joseph A Janicki

Principal Investigator

Ann and Robert H. Lurie Hospital Chicago

Are You a Good Fit for This Trial?

This trial is for children aged 7-17 with a recent elbow fracture called medial epicondyle fracture. They must be able to take oral medication and follow the treatment plan. Kids with other bone or muscle conditions, additional fractures around the same elbow, or who can't understand the study rules are not eligible.

Inclusion Criteria

Provision of signed and dated informed consent form by parent or legal guardian and signed assent form if participant is older than 12 years
Stated willingness to comply with all study procedures and availability for the duration of the study
My fracture happened less than 10 days ago.
See 3 more

Exclusion Criteria

I have a metabolic or neuromuscular condition.
I have other fractures near the same elbow.
A piece of my elbow bone is trapped in the joint.
See 2 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive either operative reduction with fixation or non-operative immobilization for medial epicondyle fractures

6 weeks
1 visit (in-person) for treatment initiation

Follow-up

Participants are monitored for safety and effectiveness after treatment, with assessments at 6 weeks, 3 months, 6 months, and 12 months

12 months
Multiple visits (in-person) at 6 weeks, 3, 6, and 12 months

Long-term Follow-up

Participants are monitored for long-term outcomes, including functional and patient-reported outcomes

36 months
Visits at 24 and 36 months

What Are the Treatments Tested in This Trial?

Interventions

  • cast immobilization
  • open reduction and internal fixation (ORIF)
Trial Overview The study compares two ways to treat elbow fractures in kids: surgery (ORIF) versus wearing a cast (non-operative immobilization). It's designed to see which method leads to better arm function after healing.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Active Control
Group I: Operative reduction w/ fixationExperimental Treatment1 Intervention
Group II: Non-operative immobilizationActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Ann & Robert H Lurie Children's Hospital of Chicago

Lead Sponsor

Trials
275
Recruited
5,182,000+

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Collaborator

Trials
508
Recruited
1,090,000+

Published Research Related to This Trial

Open reduction and internal fixation (ORIF) for AO/OTA type 13-C2 and -C3 distal humeral fractures in 23 patients aged over 45 years resulted in good to excellent functional outcomes, with a median Oxford Elbow Score of 42 and a median Mayo Elbow Performance Score of 85 after a minimum follow-up of 2 years.
Despite a notable complication rate, including reoperations in 4 patients, ORIF remains a reliable treatment option, yielding results comparable to total elbow arthroplasty and elbow hemiarthroplasty for similar fractures.
Good functional outcomes after open reduction and internal fixation for AO/OTA type 13-C2 and -C3 acute distal humeral fractures in patients aged over 45 years.Al-Hamdani, A., Rasmussen, JV., Olsen, BS.[2021]
In a study of 18 patients with complex distal humeral fractures, the use of a temporary spanning plate in addition to standard open reduction internal fixation (ORIF) significantly improved fracture stability and union rates, especially in challenging cases like comminuted fractures and revision fixations.
At a mean follow-up of 28.3 months, patients showed a good range of motion (mean elbow total arc of motion of 86.3°) and favorable functional outcomes (mean Mayo Elbow Performance Score of 80), indicating that this augmentation technique is both effective and safe.
Temporary spanning plate across the elbow for complex fractures of the distal humerus.Moharram, AN., Mahmoud, M., Lymona, A., et al.[2021]
In a study of 16 children under 13 years old with 17 forearm fractures, open reduction-internal fixation (ORIF) was performed successfully, showing excellent results with no complications such as infections or delayed unions.
The average follow-up of 12.3 months revealed that all fractures had minimal loss of forearm rotation (< 10 degrees), indicating that ORIF can be a safe and effective treatment option for pediatric forearm fractures when closed reduction is not suitable.
Open reduction and internal fixation of forearm fractures in children.Ortega, R., Loder, RT., Louis, DS.[2019]

Citations

Open Reduction and Fixation of Late-Presenting Pediatric ...Open reduction and K-wire fixation have proven to be successful treatment methods with satisfactory outcomes and minimal complications for ...
Retrospective study of open reduction and internal fixation . ...Open reduction and internal fixation with absorbable screws is feasible and safe in the treatment of lateral condyle fractures of the distal humerus in children ...
Casting vs Surgical Treatment of Children With Medial ...Surgical reduction and fixation of displaced fractures may increase the likelihood of bony union and potentially improve elbow stability and ...
Elbow medial approach open reduction and internal ...In summary, open reduction and internal fixation with absorbable cannulated screws via a medial approach showed satisfactory clinical efficacy ...
Closed Reduction-PerCutaneous Pinning (CRPP) vs. ...This study aims to evaluate the efficacy of Open Reduction and Internal Fixation (ORIF) and Closed Reduction and Percutaneous Pinning (CRPP) as suitable ...
Surgery vs Casting for Children's Elbow FracturesOpen reduction and internal fixation (ORIF) is generally safe, but there can be complications like avascular necrosis (loss of blood supply to bone) in some ...
Elbow medial approach open reduction and internal ...Open reduction and internal fixation through an elbow medial approach using absorbable cannulated screws demonstrates favorable clinical efficacy.
Clinical and radiological evaluation of surgical treatment ...The present study analyses the outcome of open reduction and internal fixation (ORIF) of humerus medial epicondyle fracture with the use of Kirschner (K) wires.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security